Efficacy of melflufen in multiple myeloma with mutated or deleted TP53
{{output}}
Patients with multiple myeloma bearing a deletion of chromosome 17p (del(17p)), mutation of TP53, or both have poorer prognosis compared to patients without these aberrations. We investigated the activity and mechanism of melflufen (melphalan flufenamide) in m... ...
